AIBs have “almost ZERO desire to bet on Arc” again.

Intel has come to market with its Arc Alchemist GPU, but its next-gen Arc Battlemage is worrying AIBs… AIB support for Battlemage is expected to “terrible, with almost no desire to go back to Arc“.

VIEW GALLERY – 2 PICTURES

In his latest video, Moore’s Law is Dead leaker Tom provided an October 2024 Intel Arc Battlemage GPU update that said the two expected SKUs are G31 and G21. Starting with the Intel G31, which is expected to launch with 32 Xe cores, 20Gbps GDDR6 memory on a 256-bit memory bus, PCIe 5.0 + DP2.1 support with RTX 4070 performance levels.

On the other hand, the G21 GPU will feature 20 Xe cores, GDDR6 memory at unknown speed (16Gbps, probably 18Gbps) on a 192-bit memory bus, also with PCIe 5.0 + DP2.1 support and RX 7600 XT performance level expected. However, I found some comments from MLID sources more interesting…

MLID’s source said: “Laptop Battlemage remains canceled, but at least a limited edition of at least two desktop SKUs is expected to launch within the next four months to use up the chips Intel has purchased“.

“Biostar is mentioned as a potential AIB, but other than that, overall AIB support is likely to be terrible and the willingness to bet on Arc again is almost nil. Additionally, a source specifically mentioned that AMD is going out of its way to offer good Ryzen + RDNA 4 bundles early to AIBs to entice them to invest in RDNA 4 instead of Battlemage“.

“Battlemage is expected to have far more consistent performance and much better performance than Alchemist at launch. However, there isn’t much optimism behind it from Intel as it will be forced to launch on a tight budget, won’t be competitive with RDNA 4 and the first dGPU Celestial chip is expected to still be in development will be canceled unless it sells particularly well“.